AI assistant
Medpace Holdings, Inc. — Director's Dealing 2021
Jan 8, 2021
30442_dirs_2021-01-08_479efcb2-34c2-4adc-9d82-a044921d0bcc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-01-06
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-06 | Common Stock | S | 91667 | $140.06 | Disposed | 6577420 | Direct |
| 2021-01-07 | Common Stock | S | 93552 | $140.06 | Disposed | 6483868 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $141.425. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.